Glenn van Dael

Rejuvenate Biomed is a clinical-stage platform and Belgian pipeline company founded in 2017 by Ann Belià « n. The company is committed to discovering and developing innovative combination drugs that can safely delay the onset of various age-related diseases. Rejuvenate Biomed has developed two proprietary drug discovery platforms, in silico combinagetm and in vivo celegagetm, to efficiently screen molecule libraries across a wide spectrum of age-related pathways. RJX-01, one of their drugs, is ready for a phase 2b clinical trial in sarcopenia, a musculoskeletal disease. The company is based on the Health Campus Limburg in Heusden-Zolder, BE. Ann Beliën has been the CEO since incorporation.

CMAST BVBA engages in the provision of project management, consulting, and business solutions. It offers strategic collaborations, research and development, supply chain and operations, and information technology services. The company was founded by Glenn Van Dael and Nadia De Wilde in 2008 and is headquartered in Temse, Belgium.